> Detailanzeige

Johannesson, Magnus [VerfasserIn] ; Jonsson, Bengt [Sonstige Person, Familie und Körperschaft]; Jonsson, Linus [Sonstige Person, Familie und Körperschaft]; Kobelt, Gisela [Sonstige Person, Familie und Körperschaft]; Zethraeus, Niklas [Sonstige Person, Familie und Körperschaft]

Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Book
  • Titel: Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?
  • Beteiligte: Johannesson, Magnus [VerfasserIn]; Jonsson, Bengt [Sonstige Person, Familie und Körperschaft]; Jonsson, Linus [Sonstige Person, Familie und Körperschaft]; Kobelt, Gisela [Sonstige Person, Familie und Körperschaft]; Zethraeus, Niklas [Sonstige Person, Familie und Körperschaft]
  • Erschienen: [S.l.]: SSRN, [2015]
  • Umfang: 1 Online-Ressource (32 p)
  • Sprache: Englisch
  • DOI: 10.2139/ssrn.2640123
  • Identifikator:
  • Entstehung:
  • Anmerkungen: Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments October 1, 2009 erstellt
  • Beschreibung: The aim of medical innovations is to improve health. A medical innovation can be defined as the application of new medical knowledge, often but not always embodied in a product, for example a pharmaceutical drug. Improved medical knowledge is the product of investments in medical research and/or knowledge created during the use of health technologies; for example from systematic evaluations and follow-up studies.Studies have shown that improvements in health have created enormous value for society (Luce et al. 2006). Some of this value has been created from investments in medical research and the development of new medical technology, and some through the experiences gained from using these technologies in clinical practice. Some of the increased medical knowledge has improved health through changes in consumption and production patterns, for example reduced smoking and less use of hazardous chemicals.Increasingly questions are asked about the value of new technologies for health improvements in relation to the price and cost of using them within the health care system. The quest for “value for money” in spending health care resources has led to the establishment of formal institutions and mechanisms for making choices on access and use of new technologies. Pharmaceutical drugs have been leading this trend, but similar demands are increasingly put on other products, diagnostic measures and different activities for prevention and health promotion
  • Zugangsstatus: Freier Zugang